Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • NPI Medicare & Medicaid
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerPolicy UpdatesRadiology/Diagnostic ImagingAmeriHealth Caritas CAD/CADx Chest Coverage | Open…
    Ask Trek AI about this page
    CurrentAmeriHealth CaritasPolicy CCP.1496

    Computer-aided detection and diagnosis for chest imaging

    Customize your policy alerts

    Sign up for AmeriHealth Caritas Policy CCP.1496 alerts

    Get alerted when Policy CCP.1496 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy defines AmeriHealth Caritas' coverage stance for computer-aided detection (CAD) and computer-aided diagnosis (CADx) software applied to chest imaging (radiography and CT) and describes alternatives and evidentiary rationale for providers and reviewers.

    Policy Summary
    PayerAmeriHealth Caritas
    PolicyComputer-aided detection and diagnosis for chest imaging
    Policy CodePolicy CCP.1496
    Change TypeNo material changes
    Effective DateOct 1, 2021
    Last ReviewSep 1, 2025
    Next Review DateJan 1, 202757d
    Key ActionDo not bill CAD/CADx for chest radiography or chest CT; use unaided chest radiography or unaided chest CT and document indication and findings.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    Not medically necessarycoverage stance for CAD/CADx for chest imaging
    No limitations

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    policy limitations
    Alternatives: unaided radiography/CTalternative covered services listed
    Guideline uncertaintyevidence limited; prospective trials requested

    Coverage Determination

    Not medically necessary

    Coverage determination

    Primary coverage stance: Computer-aided detection or computer-aided diagnosis for chest imaging is investigational/not clinically proven and, therefore, not medically necessary.

    Use of computer-aided detection (CAD) or computer-aided diagnosis (CADx) for chest imaging (radiography or CT) is excluded from coverage. The policy considers these applications investigational and therefore not medically necessary.

    The policy states that computer-aided detection or computer-aided diagnosis for chest imaging is investigational/not clinically proven and, as a result, is not medically necessary for any chest radiography or chest CT indication.

    Evaluating pulmonary nodules, lung cancer screening contexts, and other pulmonary conditions — evidence reviewed but CAD/CADx remains investigational

    Evidence was reviewed for multiple chest imaging indications, but the policy does not make CAD/CADx medically necessary for any use.

    Indications discussed in evidence: Evaluation of solitary pulmonary nodule; lung cancer screening and incidental nodule detection; and other pulmonary conditions (such as pulmonary tuberculosis and pneumoconiosis) were studied in the literature, but evidence is heterogeneous and insufficient to support medical necessity for CAD/CADx.

    The policy reviewed systematic reviews and retrospective studies across radiography and CT; limitations include retrospective designs, heterogeneous populations, and lack of prospective validation.

    Provider Billing and Documentation Actions

    Prior Authorization

    Prior authorization not established for CAD/CADx

    The policy does not describe a prior authorization pathway for computer-aided detection (CAD) or computer-aided diagnosis (CADx) for chest imaging; CAD/CADx is described as investigational and not medically necessary.

    Step Therapy

    Alternatives: unaided radiography or CT

    No step therapy requirements are specified for CAD/CADx. When CAD/CADx is not used, the policy identifies unaided chest radiography and unaided chest CT as alternative covered services.

    • Unaided chest radiography
    • Unaided chest computed tomography

    Key Definitions

    Computer-aided detection (CAD)
    DefinitionSoftware that detects potential abnormalities on diagnostic radiology exams and highlights suspicious areas of irregularity on a previously acquired and interpreted medical image for the radiologist to reassess; acts as a 'second reader' to improve reader performance.
    PurposeHighlights suspicious areas to improve sensitivity and reduce false negatives and to support radiologist reassessment.
    Modality examplesApplied to chest imaging such as chest radiography (X‑ray) and potentially CT as adjunct 'second reader' tools.
    Regulatory noteFDA has issued 510(k) clearance for at least one CAD system using lung radiography; approval depends on intended population and system requirements.
    Clinical roleUsed to flag potential abnormalities for reassessment but considered investigational for chest imaging in this policy.

    Indications Reviewed / Coverage Status

    Evaluating pulmonary nodules, lung cancer screening contexts, and other pulmonary conditions — evidence reviewed but CAD/CADx remains investigational (1 top-level node)

    Covered indications reviewed (evidence summary) — CAD/CADx remains investigational for all listed indications.

    Indications reviewed: Evaluation of solitary pulmonary nodule (incidental or screen-detected); lung cancer screening populations (LDCT context) and incidental nodule detection; detection or evaluation of pulmonary infections and occupational lung diseases (e.g., tuberculosis, pneumoconiosis).

    Although studies report improvements in some performance metrics (e.g., sensitivity, AUC) — many are retrospective, heterogeneous, or lack patient‑centered outcome data; therefore CAD/CADx is not considered medically necessary for these indications.

    Not Covered Services

    Computer-aided detection or computer-aided diagnosis applied to chest radiography or chest CT for all indications is not covered. These uses are considered investigational and therefore not medically necessary.

    Background and Clinical Context

    A solitary pulmonary nodule is a round or oval lung lesion measuring < 3 cm that may be benign or malignant. Low-dose CT (LDCT) is the recommended screening modality for individuals at high risk for lung cancer. CAD systems function as a second reader to highlight suspicious areas on chest images, while CADx systems additionally attempt lesion characterization; however, the evidence for CAD/CADx in these contexts is limited and the policy therefore does not consider CAD/CADx medically necessary.

    Policy Summary
    PayerAmeriHealth Caritas
    PolicyComputer-aided detection and diagnosis for chest imaging
    Policy CodePolicy CCP.1496
    Change TypeNo material changes
    Effective DateOct 1, 2021
    Last ReviewSep 1, 2025
    Next Review DateJan 1, 202757d
    Key ActionDo not bill CAD/CADx for chest radiography or chest CT; use unaided chest radiography or unaided chest CT and document indication and findings.
    SourceLink
    On This Page
    Coverage DeterminationProvider Billing and Documentation ActionsKey DefinitionsIndications Reviewed / Coverage StatusNot Covered ServicesBackground and Clinical Context
    Documentation Required

    Document use of unaided chest radiography or CT

    When CAD/CADx is not used, document the use of unaided chest radiography or unaided chest CT and record the clinical indication and imaging findings consistent with standard nodule evaluation.

    • Document which unaided modality was used (chest radiograph or chest CT)
    • Document clinical indication and imaging findings consistent with nodule workup
    Denial Risk

    Denial risk: CAD/CADx considered investigational

    Claims for computer-aided detection or computer-aided diagnosis applied to chest imaging may be denied because the policy considers these technologies investigational and not medically necessary.

    • Do not expect coverage for CAD/CADx for chest radiography or chest CT; submit claims accordingly or use alternative unaided imaging modalities.
    Computer-aided diagnosis (CADx)
    DefinitionSoftware that identifies suspicious regions and characterizes lesions (for example, benign versus malignant) to assist clinical decision-making by assessing likelihood of malignancy or disease characteristics.
    FunctionAssesses user‑selected regions of interest and integrates nodule characteristics, often using metrics such as area under the ROC curve to distinguish nodules.
    Use casesApplied in lung CT for characterization of pulmonary nodules and to support diagnostic assessment and management decisions.
    Regulatory noteSeveral CADx systems for lung CT have received FDA 510(k) clearance; approval criteria vary by intended population and system requirements.
    Clinical roleProvides lesion characterization to assist clinicians, but the policy considers CADx for chest imaging investigational and not medically necessary.